Alluzience is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines (vertical lines between the eyebrows) seen at maximum frown in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient. With a fast onset and durable results, Alluzience delivers smooth, refreshed skin with minimal downtime, making it a preferred choice in aesthetic medicine.

4 in stock

Delivery and Returns

SKU: SK-00753 Category: Tags: , , , ,

Benefits

  • No reconstitution needed – eliminates dilution errors, saves time, and enhances safety.

  • Rapid onset – many patients report visible improvement within 1–3 days.

  • Longer duration – effects may last up to 6 months in many users.

  • Consistent volumetric dosing – helps reduce variability across treatments.

  • Minimal handling & waste – ready-for-use format simplifies workflow and reduces product loss.

  • Prestige & differentiation – offering a newer, premium neuromodulator can elevate your clinic’s reputation.

Features

  • Formulation – Clear, liquid solution in Speywood units (RTU)
  • 2 vials × 125 IU each (total 250 IU)
  • Indication – Temporary improvement in moderate to severe glabellar lines (vertical frown lines) in adults under 65
  • Injection interval – No more often than every 12 weeks (3 months)
  • Stability & storage – Store refrigerated (2–8 °C), in original packaging protected from light (as per SmPC)
  • Purity / excipients – Developed to exclude human- or animal-derived proteins (e.g. no lactose / no human serum albumin) for reduced immunogenicity

Why Choose

  • Economy & flexibility – The twin pack allows you to treat multiple patients or maintain backup supply with lower per-unit cost.

  • Precision & safety – Ready-to-use liquid formulation removes the margin for error in dilution, improving consistency across practitioners and sessions.

  • Faster results & retention – Patients enjoy quicker onset and potentially longer-lasting outcomes, reducing frequency of return visits and improving satisfaction.

  • Modern positioning – As one of the newer premium neuromodulators, having Alluziance in your portfolio can help you stand out in a competitive aesthetics market.

Common Uses

While the primary licensed indication is glabellar lines (frown lines), experienced practitioners often apply it—at their discretion and within safety guidelines—for:

  • Lateral canthal lines (crow’s feet)

  • Forehead lines

  • Bunny lines (nasal lines)

  • Brow lift / lateral brow elevation

  • Platysmal bands (neck)

  • Masseter reduction (subject to dose and anatomical suitability)

How It Works

  1. Injection — Administered intramuscularly into the target muscle(s).

  2. Binding & uptake — The toxin binds selectively to presynaptic cholinergic nerve terminals.

  3. SNARE protein blockade — It cleaves SNARE proteins necessary for vesicle fusion, preventing acetylcholine release.

  4. Temporary muscle relaxation — This reduces involuntary muscle contractions, softening dynamic wrinkles over time.

  5. Gradual reversal — Nerve terminals regenerate and muscle function returns, necessitating re-treatment every ~12 weeks.

Because Alluziance is pre-diluted, the concentration is consistent and requires no calculation, helping reduce treatment variation and improving safety

When does the effect begin?
Many patients see improvement within 1–3 days; some report effects as early as day 1.
How long do results last?
Clinical data supports effects lasting up to 6 months in many patients.
How often can I re-treat?
Re-treatment is recommended no sooner than every 12 weeks (3 months).
Are there side effects?
Common side effects include injection-site reactions (redness, swelling, bruising), headache, or mild discomfort. Rare but serious effects (e.g. ptosis, asymmetry, swallowing difficulty) may occur if toxin diffuses to adjacent muscles.
Can I use this in all patients?
It is not recommended for patients with known hypersensitivity to botulinum toxin or excipients, neuromuscular disorders (e.g. myasthenia gravis), pregnancy, or lactation. Always review the patient’s medical history and contraindications.